IRulya Therapeutics Inc.

IRLA · XNAS

CIK 1662774fmd_19E4P0V42K43F0WRQ1HK5F10N9Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Jun 30, 2026, 34 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).